Home/Filings/4/0000899243-20-014517
4//SEC Filing

Truitt Joseph 4

Accession 0000899243-20-014517

CIK 0000875622other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 2:32 PM ET

Size

5.5 KB

Accession

0000899243-20-014517

Insider Transaction Report

Form 4
Period: 2020-05-28
Truitt Joseph
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-05-28+130,000130,000 total
    Exercise: $63.72Exp: 2030-05-28Common Stock (130,000 underlying)
Footnotes (2)
  • [F1]The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
  • [F2]The stock options vest in four equal installments over the four-year period following the date of grant.

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1
  • filerCIK 0001452429

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 2:32 PM ET
Size
5.5 KB